Statins reduce LDL cholesterol levels and prevent ASCVD by inhibiting 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and increasing the expression of low density lipoprotein receptor (LDLR) (Grundy et al., 2018). The gene discussed is VLDLR; the disease is atherosclerosis.